trex bio limited
trex bio limited Company Information
Company Number
11176257
Website
-Registered Address
1 more london place, london, SE1 2AF
Industry
Research and experimental development on biotechnology
Telephone
-
Next Accounts Due
625 days late
Group Structure
View All
Shareholders
trex holdings inc. 100%
trex bio limited Estimated Valuation
Pomanda estimates the enterprise value of TREX BIO LIMITED at £1.1m based on a Turnover of £1.2m and 0.9x industry multiple (adjusted for size and gross margin).
trex bio limited Estimated Valuation
Pomanda estimates the enterprise value of TREX BIO LIMITED at £0 based on an EBITDA of £-10.4m and a 3.81x industry multiple (adjusted for size and gross margin).
trex bio limited Estimated Valuation
Pomanda estimates the enterprise value of TREX BIO LIMITED at £28.9m based on Net Assets of £13.4m and 2.15x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Trex Bio Limited Overview
Trex Bio Limited is a live company located in london, SE1 2AF with a Companies House number of 11176257. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in January 2018, it's largest shareholder is trex holdings inc. with a 100% stake. Trex Bio Limited is a young, small sized company, Pomanda has estimated its turnover at £1.2m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Trex Bio Limited Health Check
Pomanda's financial health check has awarded Trex Bio Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
5 Weak
Size
annual sales of £1.2m, make it smaller than the average company (£2.5m)
- Trex Bio Limited
£2.5m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Trex Bio Limited
- - Industry AVG
Production
with a gross margin of 30.2%, this company has a higher cost of product (52.2%)
- Trex Bio Limited
52.2% - Industry AVG
Profitability
an operating margin of -851.3% make it less profitable than the average company (-12.8%)
- Trex Bio Limited
-12.8% - Industry AVG
Employees
with 6 employees, this is below the industry average (39)
- Trex Bio Limited
39 - Industry AVG
Pay Structure
on an average salary of £70.4k, the company has an equivalent pay structure (£70.4k)
- Trex Bio Limited
£70.4k - Industry AVG
Efficiency
resulting in sales per employee of £203.4k, this is more efficient (£119.2k)
- Trex Bio Limited
£119.2k - Industry AVG
Debtor Days
it gets paid by customers after 92 days, this is later than average (59 days)
- Trex Bio Limited
59 days - Industry AVG
Creditor Days
its suppliers are paid after 631 days, this is slower than average (63 days)
- Trex Bio Limited
63 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Trex Bio Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 531 weeks, this is more cash available to meet short term requirements (31 weeks)
531 weeks - Trex Bio Limited
31 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 18.3%, this is a lower level of debt than the average (54.7%)
18.3% - Trex Bio Limited
54.7% - Industry AVG
TREX BIO LIMITED financials
Trex Bio Limited's latest turnover from December 2020 is estimated at £1.2 million and the company has net assets of £13.4 million. According to their latest financial statements, we estimate that Trex Bio Limited has 6 employees and maintains cash reserves of £15.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|
| Turnover | |||
| Other Income Or Grants | |||
| Cost Of Sales | |||
| Gross Profit | |||
| Admin Expenses | |||
| Operating Profit | |||
| Interest Payable | |||
| Interest Receivable | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Dividends Paid | |||
| Retained Profit | |||
| Employee Costs | |||
| Number Of Employees | 1 | 2 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 |
| Investments & Other | 8 | 8 | 0 |
| Debtors (Due After 1 year) | 1,066,280 | 1,100,146 | 0 |
| Total Fixed Assets | 1,066,288 | 1,100,154 | 0 |
| Stock & work in progress | 0 | 0 | 0 |
| Trade Debtors | 309,299 | 1,975,328 | 1,060,166 |
| Group Debtors | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 |
| Cash | 15,071,762 | 13,752,853 | 13,673,511 |
| misc current assets | 0 | 0 | 8 |
| total current assets | 15,381,061 | 15,728,181 | 14,733,685 |
| total assets | 16,447,349 | 16,828,335 | 14,733,685 |
| Bank overdraft | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 |
| Trade Creditors | 1,473,907 | 35,236 | 292,546 |
| Group/Directors Accounts | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 |
| other current liabilities | 0 | 861,239 | 71,485 |
| total current liabilities | 1,473,907 | 896,475 | 364,031 |
| loans | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 |
| other liabilities | 1,535,619 | 4,044,275 | 0 |
| provisions | 0 | 0 | 0 |
| total long term liabilities | 1,535,619 | 4,044,275 | 0 |
| total liabilities | 3,009,526 | 4,940,750 | 364,031 |
| net assets | 13,437,823 | 11,887,585 | 14,369,654 |
| total shareholders funds | 13,437,823 | 11,887,585 | 14,369,654 |
| Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Profit | |||
| Depreciation | 0 | 0 | |
| Amortisation | 0 | 0 | |
| Tax | |||
| Stock | 0 | 0 | 0 |
| Debtors | -1,699,895 | 2,015,308 | 1,060,166 |
| Creditors | 1,438,671 | -257,310 | 292,546 |
| Accruals and Deferred Income | -861,239 | 789,754 | 71,485 |
| Deferred Taxes & Provisions | 0 | 0 | 0 |
| Cash flow from operations | |||
| Investing Activities | |||
| capital expenditure | |||
| Change in Investments | 0 | 8 | 0 |
| cash flow from investments | |||
| Financing Activities | |||
| Bank loans | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 |
| other long term liabilities | -2,508,656 | 4,044,275 | 0 |
| share issue | |||
| interest | |||
| cash flow from financing | |||
| cash and cash equivalents | |||
| cash | 1,318,909 | 79,342 | 13,673,511 |
| overdraft | 0 | 0 | 0 |
| change in cash | 1,318,909 | 79,342 | 13,673,511 |
trex bio limited Credit Report and Business Information
Trex Bio Limited Competitor Analysis
Perform a competitor analysis for trex bio limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
trex bio limited Ownership
TREX BIO LIMITED group structure
Trex Bio Limited has no subsidiary companies.
Ultimate parent company
TREX BIO LIMITED
11176257
trex bio limited directors
Trex Bio Limited currently has 5 directors. The longest serving directors include Dr Peter Hirth (Jun 2019) and Mr Michael Ross (Jan 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Peter Hirth | 73 years | Jun 2019 | - | Director | |
| Mr Michael Ross | England | 74 years | Jan 2020 | - | Director |
| Mr Marion Erwin.jr. | 63 years | Sep 2020 | - | Director | |
| Dr Carol Gallagher | 60 years | Sep 2020 | - | Director | |
| Mr Travis Coy | United Kingdom | 43 years | Jul 2021 | - | Director |
P&L
December 2020turnover
1.2m
-60%
operating profit
-10.4m
0%
gross margin
30.2%
-5.61%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2020net assets
13.4m
+0.13%
total assets
16.4m
-0.02%
cash
15.1m
+0.1%
net assets
Total assets minus all liabilities
trex bio limited company details
company number
11176257
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
January 2018
age
6
accounts
Unaudited Abridged
ultimate parent company
previous names
cingularity therapeutics limited (May 2018)
incorporated
UK
address
1 more london place, london, SE1 2AF
last accounts submitted
December 2020
trex bio limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to trex bio limited.
trex bio limited Companies House Filings - See Documents
| date | description | view/download |
|---|
